Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
9.01M
-
Shares change
-
+8.86M
-
Total reported value, excl. options
-
$238M
-
Value change
-
+$234M
-
Number of buys
-
47
-
Price
-
$26.79
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q2 2018
49 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q2 2018.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.01M shares
of 23.6M outstanding shares and own 38.15% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (1.59M shares), Cormorant Asset Management, LP (1.53M shares), Capital World Investors (1.1M shares), Alphabet Inc. (714K shares), Artal Group S.A. (525K shares), PRICE T ROWE ASSOCIATES INC /MD/ (500K shares), FIL Ltd (433K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (250K shares), BAKER BROS. ADVISORS LP (235K shares), and Partner Fund Management, L.P. (198K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.